Regional Director, Interventional Radiology Coordinators - West
Overview:
Replimune’s mission is to revolutionize cancer treatment with therapies designed to activate a powerful and durable full-body anti-tumor response, boldly transforming cancer care because patient’s lives depend on it. We imagine a world where cancer is a curable disease.
At Replimune, we live by our values:
United: We Collaborate for a Common Goal.Audacious: We Are Bold and Innovative.
Dedicated: We Give Our Full Commitment.
Candid: We Are Honest With Each Other.
People are at the center of everything we do, and when it comes to our employees, we make it personal. With a deep sense of purpose, an innovative and collaborative culture, a competitive and forward-looking total rewards program, everyone at Replimune has a unique opportunity to contribute to the meaningful work we do.
Join us, as we reshape the future.
The Regional Director, Interventional Radiology Coordinators – West will build and lead a regional team of Interventional Radiology Coordinators to help successfully support the launch of our emerging skin cancer portfolio.
The Director will report to the Executive Director of Multi-Channel and Customer Engagement Marketing and is a field-based role, working in close collaboration with the Sr. Director of the East Region Oncology Nurse Educator and Interventional Radiology Coordinator team.A key element of this role is to help ensure we maintain a clear, patient focused culture while operating as one team.
This person will be a key leader within the commercial organization and will work closely with cross-functional teams, including Marketing, Sales, Commercial Operations, Training & Development, Market Access & Strategic Accounts, Legal, and Compliance.
A high level of emphasis will be placed on elevating confidence in the RP1 injection process, ensuring understanding of the patient journey between specialists while creating vocal advocacy and creating a positive first experience for the patient and all relevant stakeholders.
This is a Field Based position. The incumbant must be located in the western half of the United States.
Responsibilities:
Role Description
The Director is responsible for building and sustaining a high-performing and diverse team of experienced professionals with deep interventional radiology experience who will be focusing on:
- Ensure IR preparedness to handle/administer RP1
- Provide On-Label education (efficacy, safety, dosing, AE Management)
- Advocate for Melanoma Tumor Board Attendance
- Attend and participate in IR specific conferences
- Provide logistics guidance/support
- Understand Referral Patterns and potential impact to the patient journey across the MedOnc – IR settings
- Provide RP1 logistical and operational guidance/support to account stakeholders
- Support integration into Electronic Medical Records
- Biosafety and handling education on RP1
- Provide guidance on appropriate RP1 superficial injection techniques (lesion selection, dosing, Oncology coordination) as needed
- Provide on-site support of first RP1 administration (or on-demand as requested)
- Educate staff with respect to RP1 patient/ caregiver treatment discussions
This leader will embody our culture while maintaining accountability for gathering and sharing insights, maximizing presentation opportunities, strategic planning, and flawless execution across his or her team.
Behaviors that are critical for this leader to display include an innovative mind-set, strategic thinking, strong collaboration and communication skills, relationship building, people leadership, and the ability to support your teams successful execution while providing timely and relevant feedback.
The ideal candidate will have a background in Interventional Radiology experiences and prior experience in building out teams in a similar sized or larger biotechnology organization (ideally within the skin cancer space), with an entrepreneurial spirit and willingness to play a hands-on role in supporting launch excellence.
Role Responsibilities- Design, build and implement a high performing and diverse team of Clinical Educators
- Provide key input on the company culture and approach
- Develop KPIs with tools and measures to assure transparency and success
- Maintaining a compliant, patient-centric approach in everything we do
- Be an active contributor into the annual business/brand planning process
- Prepare key deliverables for appropriate internal stakeholders
- Ensure strong collaboration and alignment across customer facing teams
- Identify, develop and lead opportunities for key strategic partnerships with relevant societies and conferences to support insight generation, educational outreach and strong external collaboration
Qualifications:
- - Bachelor’s Degree required; graduate degree a plus
- Minimum of 10+ years of pharma/biotech or related experience with at least 5 years of experience in interventional radiology; skin cancer and/or PD1 experience preferred
- A minimum of 5 years+ of people leadership experience, with a preference towards experience in Oncology
- Passionate about providing a first-rate customer experience to internal & external customers; strong ability to communicate with a data driven focus
- Excellent communication skills
- Strong time management skills including the ability to multi-task on various projects and to prioritize under fixed schedules and in high pressure situations
This is a Field Based position. The incumbant must be located in the western half of the United States.
About Replimune
Replimune Group, Inc., headquartered in Woburn, MA, was founded in 2015 with the mission to transform cancer treatment by pioneering the development of a novel portfolio of oncolytic immunotherapies. Replimune’s proprietary RPx platform is based on a potent HSV-1 backbone intended to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response.The RPx platform is designed to have a unique dual local and systemic activity consisting of direct selective virus-mediated killing of the tumor resulting in the release of tumor derived antigens and altering of the tumor microenvironment to ignite a strong and durable systemic response.
The RPx product candidates are expected to be synergistic with most established and experimental cancer treatment modalities, leading to the versatility to be developed alone or combined with a variety of other treatment options. For more information, please visit www.replimune.com.
We are an Equal Opportunity Employer.